Delante, Mayline .

HRN: 11-29-27  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2022
AMPICILLIN 1GM (VIAL)
11/17/2022
11/23/2022
IV
2GM
Q6
PROM
Waiting Final Action 
11/18/2022
CEFUROXIME 500MG (TAB)
11/18/2022
11/25/2022
ORAL
500mg/tab
BID
S/P NSVD; THICKLY MSAF
Waiting Final Action 
11/18/2022
METRONIDAZOLE 500MG (TAB)
11/18/2022
11/25/2022
ORAL
500mg/tab
TID
S/P NSVD; THICKLY MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: